BEI
ANIX icon

Benjamin Edwards Inc’s Anixa Biosciences ANIX Stock Holding History

Benjamin Edwards Inc’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.4K Hold
11,200
– – ﹤0.01% 1418
2026
Q1 		$28.9K Hold
11,200
– – ﹤0.01% 1351
2025
Q4 		$34.9K Hold
11,200
– – ﹤0.01% 1309
2025
Q3 		$37K Hold
11,200
– – ﹤0.01% 1289
2025
Q2 		$37K Buy
+11,200
New +$32K ﹤0.01% 1142

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Benjamin Edwards Inc's ANIX Position: Q2 2026 in Review

Benjamin Edwards Inc held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 11,200 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1418.

Benjamin Edwards Inc first reported a position in ANIX in Q2 2025 and has held it in 5 quarters since. The position peaked at $37K in Q3 2025. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Benjamin Edwards Inc held 11,200 shares of Anixa Biosciences worth $31.4K as of Q2 2026.
  • Benjamin Edwards Inc left its Anixa Biosciences share count unchanged in Q2 2026.
  • Anixa Biosciences made up ﹤0.01% of Benjamin Edwards Inc's portfolio in Q2 2026, its #1418 holding.
  • Benjamin Edwards Inc first reported a position in Anixa Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Benjamin Edwards Inc's Anixa Biosciences position peaked at $37K in Q3 2025.
  • 62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.